Loading...
Alemtuzumab for Multiple Sclerosis
Alemtuzumab is a humanised anti-CD52 monoclonal antibody approved for use in active, relapsing multiple sclerosis (MS). Administration results in a rapid depletion of circulating lymphocytes with a subsequent beneficial immune reconstitution. Early open-label experience and recent clinical trials ha...
Na minha lista:
| Udgivet i: | Curr Neurol Neurosci Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4971037/ https://ncbi.nlm.nih.gov/pubmed/27485945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11910-016-0685-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|